{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:51:16Z","timestamp":1778118676209,"version":"3.51.4"},"reference-count":40,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3201\/eid2310.170488","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T13:16:17Z","timestamp":1505222177000},"page":"1657-1663","source":"Crossref","is-referenced-by-count":32,"title":["Antimicrobial Drug Prescription and<i>Neisseria gonorrhoeae<\/i>Susceptibility, United States, 2005\u20132013"],"prefix":"10.3201","volume":"23","author":[{"given":"Robert D.","family":"Kirkcaldy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monina G.","family":"Bartoces","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olusegun O.","family":"Soge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Kubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Papp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Edward W.","family":"Hook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri A.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2310.170488-201709171648-R1","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013 [cited 2017 May 2]. http:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf"},{"key":"key-10.3201\/eid2310.170488-201709171648-R2","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"key":"key-10.3201\/eid2310.170488-201709171648-R3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.7326\/0003-4819-158-5-201303050-00004","article-title":"Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.","volume":"158","author":"Kirkcaldy","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid2310.170488-201709171648-R4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility surveillance\u2014The Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014.","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"key-10.3201\/eid2310.170488-201709171648-R5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/infdis\/144.2.191","article-title":"Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980.","volume":"144","author":"Jaffe","year":"1981","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00007435-200106000-00001","article-title":"Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999.","volume":"28","author":"Trees","year":"2001","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/01.olq.0000145846.45781.a4","article-title":"Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990-2000: role of foreign importation and increasing endemic spread.","volume":"31","author":"Iverson","year":"2004","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1086\/377500","article-title":"Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.","volume":"37","author":"Wang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S1473-3099(13)70693-5","article-title":"Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.","volume":"14","author":"Grad","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/cid\/cir443","article-title":"Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.","volume":"53","author":"Hicks","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3201\/eid0803.010192","article-title":"A European study on the relationship between antimicrobial use and antimicrobial resistance.","volume":"8","author":"Bronzwaer","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R12","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3201\/eid1411.070467","article-title":"Antimicrobial drug use and resistance in Europe.","volume":"14","author":"van de Sande-Bruinsma","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10096-007-0321-5","article-title":"Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae.","volume":"26","author":"Riedel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R14","unstructured":"Boardman C. inventor; IMS Health Incorporated, assignee. System and method for estimating product distribution using a product specific universe. United States patent US 7174304. 2007 Feb 6."},{"key":"key-10.3201\/eid2310.170488-201709171648-R15","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/civ076","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011.","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R16","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015.","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid2310.170488-201709171648-R17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1128\/JCM.03032-15","article-title":"Performance and verification of a real-time PCR assay targeting the gyrA gene for prediction of ciprofloxacin resistance in Neisseria gonorrhoeae.","volume":"54","author":"Hemarajata","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2310.170488-201709171648-R18","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-sixth informational supplement (M100\u2013S26). Wayne (PA): The Institute; 2016."},{"key":"key-10.3201\/eid2310.170488-201709171648-R19","unstructured":"Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. 2nd ed. Thousand Oaks (CA): Sage Publications; 2002."},{"key":"key-10.3201\/eid2310.170488-201709171648-R20","doi-asserted-by":"crossref","unstructured":"Singer JD, Willett JB. Applied longitudinal data analysis: modeling change and event occurrence. Oxford\/New York: Oxford University Press; 2003.","DOI":"10.1093\/acprof:oso\/9780195152968.001.0001"},{"key":"key-10.3201\/eid2310.170488-201709171648-R21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1542\/peds.2014-1781","article-title":"Race, otitis media, and antibiotic selection.","volume":"134","author":"Fleming-Dutra","year":"2014","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid2310.170488-201709171648-R22","first-page":"1041","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001.","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2310.170488-201709171648-R23","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2013: Gonococcal Isolate Surveillance Project (GISP) supplement and profiles cited [cited 2017 May 2]. http:\/\/www.cdc.gov\/std\/gisp2013\/gisp-2013-all-profiles.pdf"},{"key":"key-10.3201\/eid2310.170488-201709171648-R24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3201\/eid0804.010312","article-title":"Antimicrobial use and antimicrobial resistance: a population perspective.","volume":"8","author":"Lipsitch","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00007435-198801000-00011","article-title":"Penicillinase-producing Neisseria gonorrhoeae in Dade County, Florida: evidence of core-group transmitters and the impact of illicit antibiotics.","volume":"15","author":"Zenilman","year":"1988","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1086\/432801","article-title":"Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.","volume":"41","author":"Bauer","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R27","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1056\/NEJM197704212961610","article-title":"Treatment of gonorrhea \u2014 is penicillin pass\u00e9.","volume":"296","author":"McCormack","year":"1977","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2310.170488-201709171648-R28","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1001\/jama.2015.10347","article-title":"Trends in Neisseria gonorrhoeae susceptibility to cephalosporins in the United States, 2006\u20132014.","volume":"314","author":"Kirkcaldy","year":"2015","journal-title":"JAMA"},{"key":"key-10.3201\/eid2310.170488-201709171648-R29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/OLQ.0b013e3182685d2b","article-title":"Emergence of increased azithromycin resistance during unsuccessful treatment of Neisseria gonorrhoeae infection with azithromycin (Portland, OR, 2011).","volume":"39","author":"Soge","year":"2012","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1258\/0956462971920127","article-title":"Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin.","volume":"8","author":"Young","year":"1997","journal-title":"Int J STD AIDS"},{"key":"key-10.3201\/eid2310.170488-201709171648-R31","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.","volume":"16","author":"Ison","year":"2011","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2310.170488-201709171648-R32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1056\/NEJM198707303170504","article-title":"Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae.","volume":"317","author":"Boslego","year":"1987","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2310.170488-201709171648-R33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance.","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"key-10.3201\/eid2310.170488-201709171648-R34","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/infdis\/jis277","article-title":"Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.","volume":"205","author":"Kunz","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R35","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1086\/648428","article-title":"Pharyngeal gonorrhea: an important reservoir of infection?","volume":"49","author":"Weinstock","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R36","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","article-title":"Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime.","volume":"46","author":"Ameyama","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2310.170488-201709171648-R37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00007435-199501000-00007","article-title":"Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important?","volume":"22","author":"Moran","year":"1995","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/jac\/dkv319","article-title":"Trends in the use of prescription antibiotics: NHANES 1999-2012.","volume":"71","author":"Frenk","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2310.170488-201709171648-R39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/OLQ.0000000000000312","article-title":"Comparison of antimicrobial susceptibility of urogenital Neisseria gonorrhoeae isolates obtained from women and men.","volume":"42","author":"Kidd","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid2310.170488-201709171648-R40","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1128\/AAC.01277-13","article-title":"The FDA reboot of antibiotic development.","volume":"57","author":"Shlaes","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/23\/10\/17-0488_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:13:28Z","timestamp":1750875208000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/23\/10\/17-0488_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2310.170488","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}